Hemolytic Uremic Syndrome-associated Encephalopathy Successfully Treated with Corticosteroids

  • Hosaka Takashi
    Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Nakamagoe Kiyotaka
    Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Tamaoka Akira
    Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Japan

Search this article

Description

<p>The encephalopathy that occurs in association with hemolytic uremic syndrome (HUS), which is caused by enterohemorrhagic Escherichia coli (E. coli), has a high mortality rate and patients sometimes present sequelae. We herein describe the case of a 20-year-old woman who developed encephalopathy during the convalescent stage of HUS caused by E.coli O26. Hyperintense lesions were detected in the pons, basal ganglia, and cortex on diffusion-weighted brain MRI. From the onset of HUS encephalopathy, we treated the patient with methylprednisolone (mPSL) pulse therapy alone. Her condition improved, and she did not present sequelae. Our study shows that corticosteroids appear to be effective for the treatment of some patients with HUS encephalopathy. </p>

Journal

  • Internal Medicine

    Internal Medicine 56 (21), 2937-2941, 2017

    The Japanese Society of Internal Medicine

References(13)*help

See more

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top